Skin homeostasis during inflammation: A role for nerve growth factor

Histology and Histopathology

Volumn 23, Issue 1, 2008, Pages 1-10

  Sivilia, S ^a   Paradisi, M ^a   D'Intino, G ^a   Fernandez, M ^a   Pirondi, S ^a   Lorenzini, L ^a   Calza L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CFA; CGRP; NGF; P75; Skin

Indexed keywords

RATTUS;

CALCITONIN GENE RELATED PEPTIDE; FREUND ADJUVANT; MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; HOMEOSTASIS; INFLAMMATION; KERATINOCYTE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SENSORY NERVE CELL; SKIN; SPRAGUE DAWLEY RAT;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; FREUND'S ADJUVANT; HOMEOSTASIS; INFLAMMATION; KERATINOCYTES; MALE; NERVE GROWTH FACTOR; NEURONS, AFFERENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RNA, MESSENGER; SKIN;

EID: 35748949273     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Adly M.A., Assaf H.A., Hussein M.R. and Paus R. (2006). Analysis of the expression pattern of glial cell line-derived neurotrophic factor, neurturin, their cognate receptors GFRalpha-1 and GFRalpha-2, and a common signal transduction element c-Ret in the human scalp skin. J. Cutan. Pathol. 33, 799-808.
2. Albers K.M., Wright D.E. and Davis B.M. (1994). Overexpression of nerve growth factor in epidermis of transegenic mice causes hypertrophyof the peripheral nervous system. J. Neurosci. 14, 1422-1432.
3. Allen S.J. and Dawbarn D. (2006). Clinical relevance of the neurotrophins and their receptors. Clin. Sci. (Lond) 110, 175-191.
4. Aloe L. (2004). Nerve growth factor, human skin ulcers and vascularization. Our experience. Prog. Brain Res. 146, 515-522.
5. Aloe L. and Calzà L. (eds). (2004). NGF and related molecules in health and disease. Prog. Brain Res. Elsevier B.V. Amsterdam. 146.
6. Anand P. (2004). Neurotrophic factors and their receptors in human sensory neuropathies. Prog. Brain Res. 146, 477-492.
7. Bennet G., Al-Rashed S., Hoult R.J. and Brain S.D. (1998). Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain 77, 315-322.
8. Botchkarev V.A., Botchkareva N.V., Peters E.M. and Paus R. (2004). Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Prog. Brain Res. 146, 493-513.
9. Boyle M.D., Lawman M.J., Gee A.P. and Young M. (1985). Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J. Immunol. 134, 564-568.
10. Calzà L., Pozza M., Zanni M., Manzini C.U., Manzini E. and Hokfelt T. (1998). Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 82, 575-589.
11. Calzà L., Pozza M., Arletti R., Manzini E. and Hökfelt T. (2000). Longlasting regulation of opiate, galanin and other peptides in dorsal root ganglia and spinal cord during experimental polyarthritis. Exp. Neurol. 164, 333-343.
12. Chai J., Herrmann D.N., Stanton M., Barbano R.L. and Logigian E.L. (2005). Painful small-fiber neuropathy in Sjogren syndrome. Neurology 65, 925-927.
13. Chen J., Luo C., Li H. and Chen H. (1999). Primary hyperalgesia to mechanical and heat stimuli following subcutaneous bee venom injection into the plantar surface of hindpaw in the conscious rat: a comparative study with the formalin test. Pain 83, 67-76.
14. Christianson J.A., Riekhof J.T. and Wright D.E. (2003). Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 179, 188-199.
15. Constantinou J., Reynolds M.L., Woolf C.J., Safieh-Garabedian B. and Fitzgerald M. (1994). Nerve growth factor levels in developing rat skin: upregulation following skin wounding. Neuroreport 21, 2281-2284.
16. Davies A.M., Bandtlow C., Heumann R., Korsching S., Rohrer H. and Thoenen H. (1987). Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature 326, 353-358.
17. DeLeo J.A. and Yezierski R.P. (2001). The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90, 1-6.
18. Di Marco E., Marchisio P.C., Bondanza S., Franzi A.T., Cancedda R. and De Luca M. (1991). Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J. Biol. Chem. 266, 718-721.
19. Dou Y.-C., Hagstromer L., Emtestam and Johansson O. (2006). Increased nerve growth factor and its receptor in atopic dermatitis: an immunohistochemical study. Arch. Dermatol. Res. 298, 31-37.
20. Foster P.A., Wicks S., Foster M. and Brain S.D. (2002). Cellular pathology changes in rat skin following intradermal injection of nerve growth factor: neutrophil-dependent and -independent events. J. Pathol. 197, 245-255.
21. Foster P.A., Costa S.K.P., Poston R., Hoult J.R.S. and Brain S.D. (2003). Endothelial cells play an essential role in the thermal hyperalgesia induced by nerve growth factor. FASEB J. 17, 1703-1705.
22. Gee A.P., Boyle M.D., Munger K.L., Lawman M.J. and Young M. (1983). Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc. Natl. Acad Sci. USA 80, 7215-7218.
23. Giuliani A., Fernandez M., Farinelli M., Baratto L., Capra R., Rovetta G., Monteforte P., Giardino L. and Calzà L. (2004). Very low level laser therapy attenuates edema and pain in experimental models. Int. J. Tissue React. 26, 29-37.
24. Groneberg D.A., Serowka F., Peckenschneider N., Artuc M., Grutzkau A., Fischer A., Henz B.M. and Welker P. (2005). Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J. Neuroimmunol. 161, 87-92.
25. Hefty F.F., Rosenthal A., Walicke P.A., Wyatt S., Vergara G., Shelton D.L. and Davies A.M. (2006). Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci. 27, 85-91.
26. Hokfelt T., Zhang X. and Wiesenfeld-Hallin Z. (1994). Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17, 22-30.
27. Holmdahl R., Lorentzen J.C., Lu S., Olofsson P., Wester L., Holmberg J. and Pettersson U. (2001). Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 184, 184-202.
28. Horiuchi Y., Bae S. and Katayama I. (2005). Nerve growth factor (NGF) and epidermal nerve fibers in atopic dermatitis model NC/Nga mice. J. Dermatol. Sci. 39, 56-58.
29. Hsieh S.T. and Lin W.M. (1999). Modulation of keratinocyte proliferation by skin innervation. J. Invest. Dermatol. 113, 579-586.
30. Johnson P.C., Beggs J.L., Olafsen A.G. and Watkins C.J. (1994). Unmyelinated nerve fiber estimation by immunocytochemistry. Correlation with electron microscopy. J. Neuropathol. Exp. Neurol. 53, 176-183.
31. Kawamoto K. and Matsuda H. (2004). Nerve growth factor and wound healing. Prog. Brain Res. 146, 369-384.
32. Lauria G. (2005). Small fibre neuropathies. Curr. Opin. Neurol. 18, 591-597.
33. Lawman M.J., Boyle M.D., Gee A.P. and Young M. (1985). Nerve growth factor accelerates the early cellular events associated with wound healing. Exp. Mol. Pathol. 43, 274-281.
34. Levi-Montalcini R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1164.
35. Levi-Montalcini R. and Angeletti P.U. (1968). Nerve growth factor. Physiol. Rev. 48, 534-569.
36. Lewin G.R. and Mendell L.M. (1993). Nerve growth factor in nociception. Trends Neurosci. 16, 353-359.
37. Lewin G.R., Ritter A.M. and Mendell L.M. (1993). Nerve growth factorinduced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13, 2136-2148.
38. Li L., Xian C.J., Zhong J.H. and Zhou X.F. (2003). Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism in neuropathic pain. Mol. Cell Neurosci. 23, 232-250.
39. Ma W. and Bisby M.A. (2000). Calcitonin gene-related peptide, substance P and protein gene product 9.5 immunoreactive axonal fibers in the rat footpad skin following partial sciatic nerve injuries. J. Neurocytol. 29, 249-262.
40. Malik-Hall M., Dina O.A. and Levine J.D. (2005). Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur. J. Neurosci. 21, 3387-3394.
41. Mapp I., Kidd B.L., Gibson S.J., Terry J.M., Revell P.A., Ibrahim N.B., Blaje D.R. and Polak J.M. (1990). Substance P-, calcitonin generelated peptide- and C-flanking peptide of neuropeptide Y- immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 37, 143-153.
42. Marchand F., Perretti M. and McMahon S.B. (2005). Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6, 521-532.
43. Matsuda H., Koyama H., Sato H., Sawada J., Itakura A., Tanaka A., Matsumoto M., Konno K., Ushio H. and Matsuda K. (1998). Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J. Exp. Med. 187, 297-306.
44. McMahon S.B. (1996). NGF as a mediator of inflammatory pain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351, 431-440.
45. McMahon S.B., Cafferty W.B.J. and Marchand F. (2005). Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444-462.
46. Moalem G. and Tracey D.J. (2005). Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 51, 240-264.
47. Myers R.R., Campana W.M. and Shubayev V.I. (2006). The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Tod. 11, 8-20.
48. Oaklander A.L. and Siegel S.M. (2005). Cutaneous innervation: form and function. J. Am. Acad. Dermatol. 53, 1027-1037.
49. Peters E.M., Stieglitz M.G., Liezman C., Overall R.W., Nakamura M., Hagen E., Klapp B.F., Arck P. and Paus R. (2006a). p75 neurotrophin receptor-mediated signaling promotes human hair follicle regression (Catagen). Am. J. Pathol. 168, 221-234.
50. Peters E.M., Hendrix S., Golz G., Klapp B.F., Arck P.C. and Paus R. (2006b). Nerve growth factor and its precursor differentially regulate hair cycle progression in mice. J. Histochem. Cytochem. 54, 275-288.
51. Pincelli C., Sevignani C., Manfredini R., Grande A., Fantini F., Bracci-Laudiero L., Aloe L., Ferrari S., Cossarizza A. and Giannetti A. (1994). Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J. Invest. Dermatol. 103, 13-18.
52. Pozza M., Guerra M., Manzini E. and Calza L. (2000). A histochemical study of the rheumatoid synovium: focus on nitric oxide, nerve growth factor high affinity receptor, and innervation. J. Rheumatol. 27, 1121-1127.
53. Raychaudhuri S.P. and Raychaudhuri S.K. (2004). Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog. Brain Res. 146, 433-440.
54. Richardson J.D. and Vasko M.R. (2002). Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Therapeut. 302, 839-845.
55. Roosterman D., Goerge T., Schneider S.W., Bunnett N.W. and Steinhoff M. (2006). Neuronal control of skin function: The Skin as a neuroimmunoendocrine organ. Physiol. Rev. 86, 1309-1379.
56. Schmelz M. and Petersen L.J. (2001). Neurogenic inflammation in human and rodent skin. News Physiol. Sci. 16, 33-37.
57. Scott J., Selby M., Urdea M., Quiroga M., Bell G.I. and Rutter W.J. (1983). Isolation and Nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 302, 538-540.
58. Shun C.T., Chang Y.C., Wu H.P., Hsieh S.C., Lin W.M., Lin Y.H., Tai T.Y. and Hsieh S.T. (2004). Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 127, 1593-1605.
59. Smith P.G. and Liu M. (2002). Impaired cutaneous wound healing after sensory denervation in developing rats: effects on cell proliferation and apoptosis. Cell Tissue Res. 307, 281-291.
60. Snider W.D. and McMahon S.B. (1998). Tackling pain at the source: new ideas about nociceptors. Neuron 20, 629-632.
61. Takano N., Sakurai T. and Kurachi M. (2005). Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J. Pharmacol. Sci. 99, 277-286.
62. Troy C.M., Friedman J.E. and Friedman W.J. (2002). Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J. Biol. Chem. 37, 34295-34302.
63. Tso J.Y., Sun X.H. and Wu R. (1985). Structure of two unlinked Drosophila Melanogaster glyceraldehyde-3-phosphate dehydrogenase genes. J. Biol. Chem. 260, 8220-8228.
64. Vega J.A., Vazquez E., Naves F.J., Del Valle M.E., Calzada B. and Represa J.J. (1994). Immunohistochemical localization of the highaffinity NGF receptor (gp140-trkA) in the adult human dorsal root and sympathetic ganglia and in the nerves and sensory corpuscles supplying digital skin. Anat. Rec. 240, 579-588.
65. Wasner G., Kleinert A., Binder A., Schattschneider. and Baron R. (2005). Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J. Neurol. 252, 677-686.
66. Woolf C.J. (1996). Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351, 441-448.
67. Yaar M., Grossman K., Eller M. and Gilchrest B.A. (1991). Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J. Cell Biol. 115, 821-828.
68. Yaghoobi M.M. and Mowla S.J. (2006). Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neurosci. Lett. 397, 149-154.
69. Zimmermann M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.
70. Zimmermann M. (2001). Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429, 23-37.